Latest News: Indian share markets will be open for trading on Sunday, February 01, as the Union Budget is being presented on that day * Key Highlights of Economic Survey 2025–26: GDP & GVA Growth Estimates for FY 2026: First advance estimates at 7.4% and 7.3% respectively * India’s Core Growth Projection: Around 7%, with real GDP growth for FY 2027 expected between 6.8% and 7.2% * Central Government Revenue: Rose to 11.6% of GDP in FY 2025 * Non-Performing Assets: Declined to a multi-decade low of 2.2% * PMJDY Accounts: Over 552 million bank accounts opened by March 2025; 366 million in rural and semi-urban areas * Investor Base: Surpassed 120 million by September 2025, with women comprising ~25% * Global Trade Share: India’s export share doubled from 1% in 2005 to 1.8% in 2024 * Services Export: Reached an all-time high of $387.6 billion in FY 2025, up 13.6% * Global Deposits: India became the largest recipient in FY 2025 with $135.4 billion * Foreign Exchange Reserves: Hit $701.4 billion on January 16, 2026—covering 11 months of imports and 94% of external debt * Inflation: Averaged 1.7% from April to December 2025 * Foodgrain Production: Reached 357.73 million metric tons in 2024–25, up 25.43 MMT from the previous year * PM-Kisan Scheme: Over ₹4.09 lakh crore disbursed to eligible farmers since inception * Rural Employment Alignment: “Viksit Bharat – Jee Ram Ji” initiative launched to replace MGNREGA in the vision for a developed India by 2047 * Manufacturing Growth: 7.72% in Q1 and 9.13% in Q2 of FY 2026 * PLI Scheme Impact: ₹2 lakh crore in actual investment across 14 sectors; production and sales exceeded ₹18.7 lakh crore; over 1.26 million jobs created by September 2025 * Semiconductor Mission: Domestic capacity boosted with ₹1.6 lakh crore invested across 10 projects * Railway High-Speed Corridor: Expanded from 550 km in FY 2014 to 5,364 km; 3,500 km added in FY 2026 * Civil Aviation: India became the third-largest domestic air travel market; airports increased from 74 in 2014 to 164 in 2025 * DISCOMs Turnaround: Recorded first-ever positive PAT of ₹20,701 crore in FY 2025 * Renewable Energy: India ranked third globally in total renewable and installed solar capacity * Satellite Docking: India became the fourth country to achieve autonomous satellite docking capability * School Enrollment Ratios: Primary – 90.9%, Upper Primary – 90.3%, Secondary – 78.7% * Higher Education Expansion: India now has 23 IITs, 21 IIMs, and 20 AIIMS; international IIT campuses established in Zanzibar and Abu Dhabi * Maternal & Infant Mortality: Declined since 1990, now below global average * E-Shram Portal: Over 310 million unorganised workers registered by January 2026; 54% are women * National Career Service Portal: Job vacancies exceeded 28 million in FY 2025 and crossed 23 million by September 2026

Researchers turn rice husks and corncobs into sustainable medication


Agricultural waste has been used to create essential medications for treating hypertension and edema by researchers from Nazarbayev University School of Engineering and Digital Sciences.

The research team, led by Prof Nurxat Nuraje, converted rice husks and corncobs into medical substances used to create prazosin and furosemide; medications already established in the treatment of high blood pressure and fluid retention.

Pharmaceutical compounds are often derived from non-renewable sources, such as fossil fuels. Inspired by limiting our dependence on oil, the researchers developed an innovative technology to synthesise drug compounds from biowaste. The process utilised continuous flow reactors, where reactants are continuously pumped into a reactor and products are continuously removed; a significant advancement in pharmaceutical drug production.

“We chose corncobs and rice husks because they contain hemicellulose, which can also be obtained from other agricultural biowastes. Hemicellulose contains many substances necessary for the synthesis of valuable molecules,” says research fellow Dr Minavar Shaimardan.

This innovation supports sustainability by converting agricultural waste into high-value pharmaceuticals, offering a cost-effective, environmentally friendly, and sustainable alternative to conventional drug production methods.

“By turning agricultural waste into essential medicines through sustainable methods, we’re taking a major step toward greener and more affordable pharmaceutical production. This innovation not only reduces dependence on fossil resources but also adds value to Kazakhstan’s agricultural byproducts. It has the potential to position our country as a leader in green pharmaceutical technologies, while contributing to global efforts in building a more sustainable and resilient healthcare system,” says Prof Nurxat Nuraje from Nazarbayev University.